VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Teleconference

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon May 07, 2024 8:19pm

123 Views

Post# 36027950

RE:RE:Teleconference

I listened enough to hear a couple of questions that challenged VPT's disappointing sales, one investor said that 2024 so far looks like a carbon copy of 2023, and that is very disappointing. In general I think Hugh received strong messages from shareholders, and understands our expectations. Can he deliver what's needed to move the SP up? That remains to be seen, but Hugh definitely heard the message.

<< Previous

Bullboard Posts

Next >>

3 TSX gold companies whose stocks are up this year